Page last updated: 2024-08-23

captopril and Diabetes Mellitus, Adult-Onset

captopril has been researched along with Diabetes Mellitus, Adult-Onset in 125 studies

Research

Studies (125)

TimeframeStudies, this research(%)All Research%
pre-199024 (19.20)18.7374
1990's59 (47.20)18.2507
2000's32 (25.60)29.6817
2010's9 (7.20)24.3611
2020's1 (0.80)2.80

Authors

AuthorsStudies
Carvalho, VF; Chaves, ADS; Insuela, DBR; Magalhães, NS; Martins, MA; Silva, PMRE1
Abouelkheir, M; El-Metwally, TH1
Abdel-Latif, H; Bassyouni, A; El-Naggar, AR; Elyamany, M; Hassanin, S; Zaafar, D1
Bult, H; Herijgers, P; Mubagwa, K; Nevelsteen, I; Van den Bergh, A; Van der Mieren, G; Vanderper, A1
Alikasifoglu, M; Dagdelen, S; Erbas, B; Erbas, T; Hayran, M; Volkan-Salanci, B1
Baradaran, HR; Khamseh, ME; Safarnejad, B1
Mirelman, D; Rabinkov, A; Rosenthal, T; Younis, F1
Felehgari, V; Khazaie, H; Malek-Khosravi, S; Mozafari, H; Rahimi, M; Rahimi, Z; Rezaei, M; Vaisi-Raygani, A; Yari, K1
Bean, JS; Kassab, GS; Lu, X; Rekhter, MD1
Barkoudah, E; Danser, AH; Fisher, ND; Hollenberg, NK; Moukarbel, GV; Nussberger, J1
Fan, X; Harris, RC; Takahashi, T; Wang, S; Yang, H; Yang, S; Zhang, MZ1
Al-Mulhim, AS; Fouad, AA; Jresat, I; Morsy, MA1
Caro, JJ; Lee, K1
Emoto, M; Hosoi, M; Inaba, M; Ishimura, E; Kawagishi, T; Matsumoto, N; Nakatani, T; Nishizawa, Y; Shoji, S; Shoji, T; Taniwaki, H1
Jacobsen, P; Parving, HH; Pietraszek, L; Rossing, K1
Kanaki, T; Matsuda, M; Naitoh, T; Tsuruzoe, N; Yotsumoto, T1
Hedner, T; Lanke, J; Niklason, A; Niskanen, L1
Brown, P; Dasgupta, T; McGrowder, D; Ragoobirsingh, D1
Aldington, SJ; Holman, RR; Kohner, EM; Matthews, DR; Stratton, IM1
Amini, M; Aminian, T; Aminorroaya, A; Gharavi, M; Janghorbani, M; Rezvanian, H1
Scheen, AJ1
Aso, Y; Inukai, T; Inukai, Y; Matsutomo, R; Nakamachi, T; Takahashi, K; Takanashi, K; Takebayashi, K; Wakabayashi, S; Yoshida, N1
Guerrero-Romero, F; Rodríguez-Morán, M1
Carrera, MJ; Micaló, T; Montanya, E; Pérez-Maraver, M; Sahun, M; Soler, J; Vinzia, C1
Liu, J; Liu, YH; Yang, L1
Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D1
Dem'iankova, IuO; Kratnov, AA; Kratnov, AE; Popov, SA1
Huang, Z; Jansson, L; Sjöholm, A2
Fisher, ND; Hollenberg, NK; Stankovic, AR1
Atkinson, AB; Bell, PM; Browne, J; Ennis, CN; Hunter, SJ; McLaughlin, DM; Sheridan, B1
Flack, JR; Molyneaux, L; Willey, K; Yue, DK1
Jeandidier, N; Klewansky, M; Pinget, M1
Bodkin, NL; Hansen, BC1
Banyai, M; Capek, M; Kautzky-Willer, A; Ludvik, B; Prager, R; Schnack, C1
Bellini, C; De Mattia, G; Faldetta, MR; Ferri, C; Laurenti, O; Properzi, G; Santucci, A1
Canessa, ML; DeFronzo, RA; Giordano, M; Matsuda, M; Sanders, L1
Campese, VM; Huang, TP; Liou, HH1
Savage, S; Schrier, RW1
Anichini, R; Bartolomei, G; Boni, C; Ferrannini, E; Sanna, G; Seghieri, G; Yin, W2
Bolli, GB; Britta, M; Brunetti, P; Perriello, G; Rambotti, AM; Santeusanio, F; Torlone, E1
Beck-Nielsen, H; Faergeman, O; Gall, MA; Gerdes, LU; Hommel, EE; Lauritzen, M; Mathiesen, ER; Rossing, P; Skøtt, P; Vølund, A1
Abad, E; Johnston, S; Lucas, A; Reverter, JL; Romero, R; Salinas, I; Sanmarti, A1
Lacourcière, Y; Nadeau, A; Poirier, L; Tancrède, G2
Alkharouf, J; Corry, D; Nalinikumari, K; Tuck, M1
Materson, BJ1
Cassone-Faldetta, M; De Mattia, G; Ferri, C; Laurenti, O; Piccoli, A; Santucci, A1
Açbay, O; Altuntaş, Y; Caner, M; Güven, M; Ince, E; Kanigür-Sultuybek, G1
Canessa, ML; Castellino, P; DeFronzo, RA; Giordano, M; Sanders, LR1
Czyzyk, A; Jasik, M; Kasperska-Dworak, A1
Fukunaga, Y; Inoue, D; Koshiyama, H; Maeda, S; Sakaguchi, H1
Campbell, O; Guasch, A; Macon, E; Nzerue, C; Parham, M; Zayas, CF1
Carraro, A; Crepaldi, G; Fasoli, G; Frigato, F; Marin, M; Nisti, S; Nosadini, R; Palisi, M; Scognamiglio, R; Virgili, F1
Dachman, W; Székács, B; Vajo, Z1
Basalka, E; Fiser, I; Seitl, K; Stanek, B1
Canessa, ML; Castellino, P; DeFronzo, RA; Giordano, M; Solini, A1
Phillips, PJ; Popplewell, PY; Tallis, GA1
Gan, P; Han, Q; Li, J; Xiao, X; Yu, M1
Kumar, PD; Rajaratnam, K1
Arrojo Arias, E; Cordero Guevara, J; del Saz Moreno, V; González Castro, ML; Sáez Fernández, A; Sagredo Pérez, J1
Edwards, EA; Lewis-Barned, NJ; Robertson, MC; Tillmann, HC; Walker, RJ1
Parving, HH1
Miser, WF1
Bermejo, A; Cabo, P; Duarte, J; Gámez, MJ; Martinez, A; Vera, B; Zarzuelo, A1
Iwamoto, Y; Iwasaki, N; Nanko, H; Wasada, T1
Grossman, E; Messerli, FH1
Atkinson, AB; Bell, PM; Ennis, CN; Hunter, SJ; Sheridan, B; Whitehead, HM; Wiggam, MI1
Chen, D; Gao, Y; Geng, J; Lü, R; Ren, K; Wang, X; Wang, Y; Yu, X; Zhao, J1
Bauduceau, B; Dupuy, O; Mayaudon, H2
Botteri, F; Cheung, R; Huff, MW; Lewanczuk, RZ; Muirhead, N; Oddou-Stock, P; Pecher, E; Rodger, NW1
Alderman, MH; Applegate, WB; Furberg, CD; Pahor, M; Psaty, BM; Williamson, JD1
Dvorak, SR1
Coca, A; Ruilope, LM1
Levinson, PD1
Ahonen, P; Saltevo, J1
Hansson, L; Hedner, T; Himmelmann, A1
Adler, A; Clarke, P; Cull, C; Gray, A; Holman, R; Neil, A; Raikou, M; Stevens, R; Stratton, I1
Larger, E; Marre, M1
Carruthers, SG1
Boner, G; Erman, A; van Dijk, DJ1
Audi, L; Lucas, A; Romero, R; Salinas, I; Sanmarti, A; Teixidó, J1
Beck-Nielsen, H; Faergeman, O; Gall, MA; Gerdes, LU; Hommel, E; Lauritzen, M; Mathiesen, ER; Rossing, P; Skøtt, P; Vølund, A1
Kawai, K; Murayama, Y; Suzuki, S; Watanabe, Y; Yamashita, K1
Bain, SC; Barnett, AH; Le Guen, CA; Lunec, J1
Agabiti-Rosei, E; Caldonazzo, A; Cravarezza, P; Giustina, A; Giustina, G; Romanelli, G1
Sandler, M; Watson, N1
Bolli, GB; Botta, G; Brunetti, P; Perriello, G; Rambotti, AM; Santeusanio, F; Torlone, E1
Felip, A; Lucas, A; Romero, R; Salinas, I; Sanmarti, A; Teixidó, J1
Arauz-Pacheco, C; Ramirez, LC; Raskin, P; Rios, JM1
Chan, MK; Cheng, IK; Ma, JT; Yeh, GR1
Bossoni, S; Caldonazzo, A; Cimino, A; Cravarezza, P; Giustina, A; Giustina, G; Romanelli, G1
Ishii, J; Itabashi, A; Katayama, S; Kawazu, S; Kodama, J; Tanaka, K1
Hiroto, S; Ishikawa, Y; Kaneko, Y; Miyakawa, T; Shindo, Y; Shionoiri, H; Takasaki, I1
Scapellato, L; Stornello, M; Valvo, EV1
Dietze, GJ; Fink, E; Jauch, KW; Mehnert, H; Rett, K; Wicklmayr, M1
Andonova, K; Koev, D; Zacharieva, S1
Leone, S; Scapellato, L; Stornello, M; Valvo, EV; Vasques, E1
Agabiti-Rosei, E; Bossoni, S; Girelli, A; Giustina, A; Giustina, G; Muiesan, G; Muiesan, ML; Romanelli, G1
Leblanc, H; Marre, M; Passa, P1
Dietze, G; Fink, E; Jauch, KW; Mehnert, H; Rett, K; Wicklmayr, M1
Gottlieb, SS; Kessler, PD; Lee, WH; Medina, N; Packer, M; Yushak, M1
Antiga, L; Bedogna, V; Bommartini, F; Casagrande, P; Maschio, G; Oldrizzi, L; Rugiu, C; Valvo, E; Zamboni, M1
Dietze, GJ; Rett, K; Wicklmayr, M1
Aguilar, M; Campos-Pastor, MM; Escobar-Jiminez, F; Fernandez Soto, ML; Garcia del Rio, C; Lobon, JA1
Dietze, G; Mehnert, H; Rett, K; Tschollar, W; Wicklmayr, M1
Dietze, G; Guenther, B; Hartl, W; Jauch, KW; Rett, K; Wicklmayr, M1
Dietze, G; Fink, E; Günther, B; Jauch, KW; Lotz, N; Rett, K; Wicklmayr, M1
Gómez Reyes, D; Rojas Hidalgo, E1
Bell, D; Clarke, BF; Collier, A; Matthews, DW; Muir, AL; Wathen, CG1
Dietze, GJ; Fink, E; Fritz, H; Günther, B; Hartl, W; Jauch, KW; Mehnert, H; Rett, K; Wicklmayr, M1
Bell, D; Clarke, BF; Collier, A; Matthews, DM; Muir, AL; Roulston, JE; Wathen, CG1
de la Calle, H; Dominguez, JR; Hurtado, A; Robles, RG; Sancho-Rof, J1
Benetollo, P; Crepaldi, G; D'Angelo, A; Gambaro, G; Giannini, S; Lavagnini, T; Malvasi, L; Sartori, L1
Carleo, R; Dell'Aversano, R; Gatti, A; Monda, M1
Fazzi, L; Ricci, F; Ricci, PD1
Cicerello, E; Crepaldi, G; D'Angelo, A; Del Turco, M; Gambaro, G; Morbiato, F; Sartori, L1

Reviews

9 review(s) available for captopril and Diabetes Mellitus, Adult-Onset

ArticleYear
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.
    Diabetes & metabolism, 2004, Volume: 30, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Humans; Hypertension; Randomized Controlled Trials as Topic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System

2004
Renal diseases in diabetes mellitus.
    Journal of the Indian Medical Association, 1997, Volume: 95, Issue:7

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Calcium Channel Blockers; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Peritoneal Dialysis, Continuous Ambulatory; Prognosis; Urinary Tract Infections

1997
Renoprotection in diabetes: genetic and non-genetic risk factors and treatment.
    Diabetologia, 1998, Volume: 41, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Risk Factors

1998
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
    Diabetes care, 2000, Volume: 23, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Randomized Controlled Trials as Topic

2000
ACE inhibitors: new hope for old drugs?
    South Dakota journal of medicine, 2000, Volume: 53, Issue:8

    Topics: Angina, Unstable; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Humans; Myocardial Infarction; Ramipril; Risk Factors

2000
[Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
    Medicina clinica, 2000, Jul-01, Volume: 115, Issue:5

    Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Kidney Diseases; Primary Prevention; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Time Factors

2000
Beta-blockers, diabetes, and hypoglycemia: risky business?
    Medicine and health, Rhode Island, 2001, Volume: 84, Issue:3

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Randomized Controlled Trials as Topic; Risk Factors; Time Factors

2001
The diabetic hypertensive (or hypertensive diabetic)--a compelling need to optimize blood pressure.
    Advances in experimental medicine and biology, 2001, Volume: 498

    Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension

2001
[Effect of the angiotensin I-converting enzyme inhibitor captopril in hypertensive diabetics without nephropathy].
    Medicina clinica, 1988, Apr-02, Volume: 90, Issue:13

    Topics: Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged

1988

Trials

57 trial(s) available for captopril and Diabetes Mellitus, Adult-Onset

ArticleYear
The Role of Vildagliptin in Treating Hypertension Through Modulating Serum VEGF in Diabetic Hypertensive Patients.
    Journal of cardiovascular pharmacology and therapeutics, 2019, Volume: 24, Issue:3

    Topics: Adult; Antihypertensive Agents; Biomarkers; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Egypt; Female; Glycated Hemoglobin; Humans; Hypertension; Insulin Resistance; Lipids; Male; Metformin; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A; Vildagliptin

2019
Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2009, Volume: 10, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Female; Genotype; Hemodynamics; Humans; Kidney; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Radioisotope Renography; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Technetium Tc 99m Mertiatide

2009
Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients?
    Journal of hypertension, 2011, Volume: 29, Issue:12

    Topics: Aldosterone; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fumarates; Humans; Irbesartan; Kidney; Male; Middle Aged; Renin-Angiotensin System; Sodium Chloride, Dietary; Tetrazoles; Treatment Outcome

2011
Intrarenal hemodynamic changes after captopril test in patients with type 2 diabetes: a duplex Doppler sonography study.
    Diabetes care, 2003, Volume: 26, Issue:1

    Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycated Hemoglobin; Heart Rate; Humans; Male; Middle Aged; Renal Circulation; Renin; Ultrasonography; Vascular Resistance

2003
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
    Diabetes care, 2003, Volume: 26, Issue:8

    Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Kidney; Lisinopril; Male; Middle Aged; Tetrazoles; Treatment Outcome

2003
Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP).
    Journal of hypertension, 2004, Volume: 22, Issue:3

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cohort Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors

2004
Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:11

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Glucose; Blood Pressure; Captopril; Cataract Extraction; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Humans; Hypertension, Renal; Laser Coagulation; Male; Middle Aged; Prospective Studies; Risk Factors; Vision Disorders; Vitreous Hemorrhage

2004
Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
    Nephron. Clinical practice, 2005, Volume: 99, Issue:3

    Topics: Adult; Aged; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Pentoxifylline; Proteinuria

2005
Pentoxifylline is as effective as captopril in the reduction of microalbuminuria in non-hypertensive type 2 diabetic patients--a randomized, equivalent trial.
    Clinical nephrology, 2005, Volume: 64, Issue:2

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Pentoxifylline; Statistics, Nonparametric; Treatment Outcome

2005
Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment.
    Diabetes research and clinical practice, 2005, Volume: 70, Issue:1

    Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Prospective Studies

2005
[Clinical observation on treatment of early diabetic nephropathy by milkvetch injection combined with captopril].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2005, Volume: 25, Issue:11

    Topics: Adult; Aged; Albuminuria; Astragalus propinquus; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Injections; Male; Middle Aged; Phytotherapy

2005
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
    Diabetes research and clinical practice, 2006, Volume: 72, Issue:3

    Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Propranolol; Ramipril; Transforming Growth Factor beta1

2006
[Lisinopril-induced changes in antioxidant defense in patients with acute coronary syndrome and concomitant diabetes mellitus type 2].
    Terapevticheskii arkhiv, 2005, Volume: 77, Issue:12

    Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Catalase; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Glutathione Reductase; Humans; Lisinopril; Male; Middle Aged; Myocardial Ischemia; Neutrophils; Oxidative Stress; Oxidoreductases; Peroxidase; Severity of Illness Index; Spectrophotometry; Superoxide Dismutase; Treatment Outcome

2005
Comparison of effects of combined ACE inhibitor and low-dose thiazide diuretic with ACE inhibitor alone on insulin action in patients with hypertension and Type 2 diabetes: a double-blind crossover study.
    Diabetic medicine : a journal of the British Diabetic Association, 2008, Volume: 25, Issue:5

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bendroflumethiazide; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Glucose Clamp Technique; Humans; Hypertension; Insulin; Insulin Resistance; Middle Aged; Treatment Outcome

2008
Regression of microalbuminuria: results of a controlled study, indapamide versus captopril.
    Journal of cardiovascular pharmacology, 1993, Volume: 22 Suppl 6

    Topics: Aged; Albuminuria; Analysis of Variance; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Radioimmunoassay

1993
Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study.
    The Clinical investigator, 1994, Volume: 72, Issue:12

    Topics: Aged; Albuminuria; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Longitudinal Studies; Male; Middle Aged; Placebos

1994
Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition.
    American journal of hypertension, 1995, Volume: 8, Issue:1

    Topics: Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelins; Humans; Insulin; Male; Middle Aged; Sensitivity and Specificity

1995
Hypertension in Diabetes Study. III. Prospective study of therapy of hypertension in type 2 diabetic patients: efficacy of ACE inhibition and beta-blockade.
    Diabetic medicine : a journal of the British Diabetic Association, 1994, Volume: 11, Issue:8

    Topics: Adult; Aged; Atenolol; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Triglycerides; United Kingdom

1994
Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases.
    Nephron, 1995, Volume: 69, Issue:1

    Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Drug Administration Schedule; Female; Glomerular Filtration Rate; Humans; Hydralazine; Kidney; Kidney Diseases; Male; Prospective Studies; Proteinuria; Renin

1995
Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.
    Diabetes care, 1993, Volume: 16, Issue:10

    Topics: Aged; Analysis of Variance; Antihypertensive Agents; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet, Diabetic; Fatty Acids, Nonesterified; Female; Glucose; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Lipid Metabolism; Male; Middle Aged

1993
[The effect of captopril, metoprolol and hydrochlorothiazide therapy in patients with non-insulin-dependent diabetes (NIDDM) and primary hypertension. A double-blind, randomized cross-over study].
    Ugeskrift for laeger, 1993, Mar-01, Volume: 155, Issue:9

    Topics: Aged; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Evaluation; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Metoprolol; Middle Aged

1993
Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors.
    Diabetes care, 1993, Volume: 16, Issue:4

    Topics: Albuminuria; Blood Glucose; Blood Pressure; Captopril; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Diastole; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Renal Circulation; Systole; Triglycerides

1993
Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.
    Hypertension (Dallas, Tex. : 1979), 1993, Volume: 21, Issue:6 Pt 1

    Topics: Aged; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Metoprolol; Middle Aged; Prospective Studies

1993
Long-term effects of the angiotensin converting enzyme inhibitor captopril on metabolic control in non-insulin-dependent diabetes mellitus.
    American journal of hypertension, 1993, Volume: 6, Issue:5 Pt 1

    Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Potassium; Time Factors

1993
Circulating catecholamines and metabolic effects of captopril in NIDDM patients.
    Diabetes care, 1996, Volume: 19, Issue:3

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Epinephrine; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Male; Norepinephrine

1996
Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients.
    Nephron, 1996, Volume: 72, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Doxazosin; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypertension; Kidney; Kidney Function Tests; Male; Middle Aged; Nifedipine; Proteinuria

1996
Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control.
    Diabetologia, 1996, Volume: 39, Issue:12

    Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Cohort Studies; Diabetes Mellitus, Type 2; Electrolytes; Female; Follow-Up Studies; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Prospective Studies; Time Factors

1996
Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy.
    Journal of the American Society of Nephrology : JASN, 1997, Volume: 8, Issue:5

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Black People; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Isradipine; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Proteinuria

1997
Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients.
    Diabetes care, 1997, Volume: 20, Issue:8

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Evaluation; Drug Tolerance; Echocardiography; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nitrendipine; Stroke Volume; Treatment Outcome

1997
Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
    Acta physiologica Hungarica, 1996, Volume: 84, Issue:4

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Chronic Disease; Diabetes Mellitus, Type 2; Enalapril; Exercise; Female; Glomerulonephritis; Humans; Male; Proteinuria

1996
Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment.
    Metabolism: clinical and experimental, 1997, Volume: 46, Issue:11

    Topics: Adult; Antihypertensive Agents; Antiporters; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Doxazosin; Erythrocytes; Female; Glucose; Glucose Clamp Technique; Humans; Hypertension; Insulin; Lithium; Male; Middle Aged; Nifedipine; Sodium; Sodium-Hydrogen Exchangers; Triglycerides

1997
A long-term comparison between enalapril and captopril on insulin sensitivity in normotensive non-insulin dependent diabetic volunteers.
    Journal of clinical pharmacy and therapeutics, 1997, Volume: 22, Issue:4

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Enalapril; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipoproteins; Male; Middle Aged; Single-Blind Method; Time Factors

1997
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
    BMJ (Clinical research ed.), 1998, Sep-12, Volume: 317, Issue:7160

    Topics: Adrenergic beta-Antagonists; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Peripheral Vascular Diseases; Prospective Studies; Proteinuria; Visual Acuity; Weight Gain

1998
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
    BMJ (Clinical research ed.), 1998, Sep-12, Volume: 317, Issue:7160

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Peripheral Vascular Diseases; Prospective Studies; Treatment Outcome; Visual Acuity; Weight Gain

1998
Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.
    BMJ (Clinical research ed.), 1998, Sep-12, Volume: 317, Issue:7160

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Cost of Illness; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Female; Health Services; Hospitalization; Humans; Hypertension; Life Expectancy; Male; Middle Aged; Prospective Studies; Quality-Adjusted Life Years; Sensitivity and Specificity; Time Factors; Treatment Outcome; United Kingdom

1998
Comparison of effects of captopril used either alone or in combination with a thiazide diuretic on insulin action in hypertensive Type 2 diabetic patients: a double-blind crossover study.
    Diabetic medicine : a journal of the British Diabetic Association, 1999, Volume: 16, Issue:6

    Topics: Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Female; Glucose Clamp Technique; Humans; Hypertension; Insulin; Male; Middle Aged; Placebos; Sodium Chloride Symporter Inhibitors

1999
A clinical trial of tang shen ning for treatment of diabetic nephropathy.
    Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 1998, Volume: 18, Issue:4

    Topics: Adult; Aged; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Qi; Yin Deficiency

1998
Efficacy of rilmenidine versus captopril on microalbuminuria: a pilot study in hypertensive type 2 diabetics.
    Cardiovascular drugs and therapy, 1999, Volume: 13, Issue:6

    Topics: Albuminuria; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Humans; Hypertension; Oxazoles; Pilot Projects; Random Allocation; Rilmenidine

1999
The effect of valsartan and captopril on lipid parameters in patients with type II diabetes mellitus and nephropathy.
    International journal of clinical practice, 1999, Volume: 53, Issue:8

    Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Tetrazoles; Valine; Valsartan

1999
Rilmenidine in the hypertensive type-2 diabetic: a controlled pilot study versus captopril.
    Journal of cardiovascular risk, 2000, Volume: 7, Issue:1

    Topics: Aged; Albuminuria; Antihypertensive Agents; Blood Pressure Determination; Captopril; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Oxazoles; Pilot Projects; Rilmenidine

2000
An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
    Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:6

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Confidence Intervals; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Family Practice; Follow-Up Studies; Glycated Hemoglobin; Hospitalization; Humans; Hypertension; Hypoglycemic Agents; Time Factors; Treatment Outcome; United Kingdom

2001
Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:4

    Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enalapril; Humans; Middle Aged; Peptidyl-Dipeptidase A; Renin; Time Factors

2000
Comparative effects of captopril versus nifedipine on proteinuria and renal function of type 2 diabetic patients.
    Diabetes research and clinical practice, 1992, Volume: 17, Issue:3

    Topics: Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Kidney Glomerulus; Male; Middle Aged; Nifedipine; Potassium; Proteinuria; Regression Analysis; Serum Albumin; Sodium

1992
Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension.
    American journal of hypertension, 1992, Volume: 5, Issue:5 Pt 1

    Topics: Aged; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Hypoglycemic Agents; Lipids; Male; Metoprolol; Middle Aged

1992
Comparison of the effects of nilvadipine and captopril on glucose and lipid metabolism in NIDDM patients with hypertension.
    Diabetes research and clinical practice, 1992, Volume: 16, Issue:2

    Topics: Analysis of Variance; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Heart Rate; Humans; Hypertension; Lipids; Male; Middle Aged; Nifedipine; Pulse

1992
Comparison of the free radical scavenging activity of captopril versus enalapril: a three month in vivo study in hypertensive diabetic patients.
    Journal of human hypertension, 1991, Volume: 5, Issue:6

    Topics: Adult; Aged; Blood Proteins; Captopril; Diabetes Mellitus, Type 2; Enalapril; Female; Free Radical Scavengers; Free Radicals; Humans; Hypertension; Lipid Peroxides; Male; Middle Aged; Thiobarbiturates

1991
Comparative effects of converting enzyme inhibition and conventional therapy in hypertensive non-insulin dependent diabetics with normal renal function.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1991, Volume: 14, Issue:6

    Topics: Aged; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Middle Aged

1991
Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Journal of human hypertension, 1991, Volume: 5, Issue:3

    Topics: Adolescent; Adult; Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Double-Blind Method; Exercise; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Time Factors

1991
Effects of captopril on glucose tolerance in elderly patients with congestive cardiac failure.
    Current medical research and opinion, 1991, Volume: 12, Issue:6

    Topics: Aged; Aged, 80 and over; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Heart Failure; Humans; Male; Prospective Studies

1991
ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension.
    Diabetologia, 1991, Volume: 34, Issue:2

    Topics: Adult; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucose; Glucose Clamp Technique; Humans; Hypertension; Insulin; Insulin Infusion Systems; Kinetics; Liver; Male

1991
Comparison of captopril and enalapril in the treatment of hypertension in patients with non-insulin dependent diabetes mellitus and nephropathy.
    International urology and nephrology, 1990, Volume: 22, Issue:3

    Topics: Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Male; Middle Aged

1990
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
    Diabetes, 1990, Volume: 39, Issue:11

    Topics: Administration, Oral; Adolescent; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Exercise; Female; Humans; Kidney Glomerulus; Male; Middle Aged; Nifedipine

1990
Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy.
    Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:6

    Topics: Adult; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Female; Heart Rate; Hemodynamics; Humans; Kidney; Kidney Function Tests; Male; Nicardipine

1989
Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1989, Volume: 7, Issue:6

    Topics: Albuminuria; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Evaluation; Exercise; Exercise Test; Humans; Hypertension; Nifedipine

1989
Effect of captopril at two different dosage regimens in hypertensive non-insulin dependent patients.
    Postgraduate medical journal, 1988, Volume: 64 Suppl 3

    Topics: Captopril; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Random Allocation

1988
Role of angiotensin-converting enzyme inhibitors in early antihypertensive treatment in non-insulin dependent diabetes mellitus.
    Postgraduate medical journal, 1988, Volume: 64 Suppl 3

    Topics: Aged; Blood Glucose; Captopril; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Middle Aged; Random Allocation

1988
Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus.
    European journal of clinical investigation, 1987, Volume: 17, Issue:5

    Topics: Alanine; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Glucose; Humans; Insulin; Male; Middle Aged; Muscles

1987

Other Studies

59 other study(ies) available for captopril and Diabetes Mellitus, Adult-Onset

ArticleYear
Effect of the renin-angiotensin system on the exacerbation of adrenal glucocorticoid steroidogenesis in diabetic mice: Role of angiotensin-II type 2 receptor.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Alloxan; Animals; Captopril; Corticosterone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucocorticoids; Mice; Renin-Angiotensin System

2022
Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme.
    European journal of pharmacology, 2019, Nov-05, Volume: 862

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enalapril; Female; Glucagon-Like Peptide 1; Humans; Hypertension; Linagliptin; Peptidyl-Dipeptidase A; Protein Binding; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate

2019
NO-dependent endothelial dysfunction in type II diabetes is aggravated by dyslipidemia and hypertension, but can be restored by angiotensin-converting enzyme inhibition and weight loss.
    Journal of vascular research, 2013, Volume: 50, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Blood Glucose; Caloric Restriction; Captopril; Combined Modality Therapy; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Dyslipidemias; Endothelium, Vascular; Female; Hypertension; Leptin; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Nitric Oxide; Receptors, LDL; Time Factors; Vasodilation; Vasodilator Agents; Weight Loss

2013
The effect of captopril on progression of retinopathy in type 2 diabetes.
    Diabetes technology & therapeutics, 2009, Volume: 11, Issue:11

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Mass Index; Captopril; Case-Control Studies; Chi-Square Distribution; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Regression Analysis

2009
S-allyl-mercapto-captopril: a novel compound in the treatment of Cohen-Rosenthal diabetic hypertensive rats.
    Journal of clinical hypertension (Greenwich, Conn.), 2010, Volume: 12, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cysteine; Diabetes Mellitus, Type 2; Diastole; Disulfides; Hypertension; Hypoglycemic Agents; Male; Rats; Rats, Inbred SHR; Sulfinic Acids; Systole

2010
The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria.
    Molecular biology reports, 2011, Volume: 38, Issue:3

    Topics: Albuminuria; Alleles; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Factor V; Female; Genetic Predisposition to Disease; Humans; Iran; Losartan; Male; Middle Aged; Mutation; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Treatment Outcome

2011
Protein kinase C inhibition ameliorates functional endothelial insulin resistance and vascular smooth muscle cell hypersensitivity to insulin in diabetic hypertensive rats.
    Cardiovascular diabetology, 2011, Jun-02, Volume: 10

    Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Femoral Artery; Hypertension; Indoles; Insulin; Insulin Resistance; Male; Maleimides; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myography; Protein Deficiency; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Telemetry; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2011
Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice.
    American journal of physiology. Renal physiology, 2012, Feb-15, Volume: 302, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hydralazine; Hydrochlorothiazide; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Renin-Angiotensin System; Reserpine

2012
Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury.
    The Journal of pharmacy and pharmacology, 2013, Volume: 65, Issue:2

    Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Caspase 3; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fas Ligand Protein; Glutathione; Heme Oxygenase (Decyclizing); Hyperglycemia; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Kidney; Kidney Diseases; Male; Malondialdehyde; Microtubule-Associated Proteins; NF-kappa B; Nitric Oxide; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Survivin; Tumor Necrosis Factor-alpha

2013
[Hypertensive patient with diabetes. "Blood pressure cosmetics" are not enough here].
    MMW Fortschritte der Medizin, 2002, Jun-13, Volume: 144, Issue:24

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Enalapril; Evidence-Based Medicine; Humans; Hypertension; Treatment Outcome

2002
An economic evaluation of atenolol vs. captopril in patients with type 2 diabetes (UKPDS 24).
    Current hypertension reports, 2002, Volume: 4, Issue:6

    Topics: Antihypertensive Agents; Atenolol; Captopril; Diabetes Mellitus, Type 2; Evaluation Studies as Topic; Health Care Costs; Hospitalization; Humans; Randomized Controlled Trials as Topic; United Kingdom

2002
A novel peroxisome proliferator-activated receptor (PPAR)gamma agonist, NIP-222, reduces urinary albumin excretion in streptozotocin-diabetic mice independent of PPARgamma activation.
    Metabolism: clinical and experimental, 2003, Volume: 52, Issue:12

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Captopril; Chromans; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Genes, Reporter; Hypoglycemic Agents; Kidney; Luciferases; Male; Mice; Organ Size; Plasmids; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Transcription Factors; Troglitazone; Urodynamics

2003
The effect of nitric oxide on glucose metabolism.
    Molecular and cellular biochemistry, 2004, Volume: 263, Issue:1-2

    Topics: Animals; Binding, Competitive; Captopril; Cell Membrane; Diabetes Mellitus, Type 2; Dogs; Female; Glucose; In Vitro Techniques; Insulin; Kinetics; Leukocytes, Mononuclear; Male; Nitric Oxide; Nitric Oxide Donors; Receptor, Insulin; S-Nitrosoglutathione

2004
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitus.
    The American journal of the medical sciences, 2005, Volume: 329, Issue:5

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Free Radical Scavengers; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Neutrophils; Superoxide Dismutase; Superoxides; Tetrazoles; Thiazepines

2005
Vasoactive drugs enhance pancreatic islet blood flow, augment insulin secretion and improve glucose tolerance in female rats.
    Clinical science (London, England : 1979), 2007, Volume: 112, Issue:1

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Irbesartan; Islets of Langerhans; Pancreas; Pravastatin; Rats; Rats, Wistar; Regional Blood Flow; Sex Factors; Tetrazoles; Vasodilator Agents

2007
Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.
    Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:12

    Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; p-Aminohippuric Acid; Reference Values; Renal Circulation; Renin; Renin-Angiotensin System; Sodium Chloride; Vasoconstriction

2006
Gender-specific regulation of pancreatic islet blood flow, insulin levels and glycaemia in spontaneously diabetic Goto-Kakizaki rats.
    Clinical science (London, England : 1979), 2008, Volume: 115, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Irbesartan; Islets of Langerhans; Male; Pravastatin; Rats; Rats, Mutant Strains; Regional Blood Flow; Sex Factors; Tetrazoles

2008
Captopril-induced acute pancreatitis.
    Diabetes care, 1995, Volume: 18, Issue:3

    Topics: Abdominal Pain; Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Pancreatitis

1995
Antihypertensive effects of captopril without adverse effects on glucose tolerance in hyperinsulinemic rhesus monkeys.
    Journal of medical primatology, 1995, Volume: 24, Issue:1

    Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diastole; Glucose Tolerance Test; Hyperinsulinism; Hypertension; Macaca mulatta; Male; Systole

1995
Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Diabetes, 1995, Volume: 44, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Captopril; Cholesterol; Diabetes Mellitus, Type 2; Doxazosin; Fatty Acids, Nonesterified; Female; Glucose; Glycated Hemoglobin; Humans; Hypertension; Insulin; Lipid Metabolism; Lipids; Male; Middle Aged; Nifedipine

1995
On recent advances in diabetes management.
    Hospital practice (Office ed.), 1994, Dec-15, Volume: 29, Issue:12

    Topics: Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Insulin; Randomized Controlled Trials as Topic

1994
Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 1994, Volume: 9, Issue:1

    Topics: Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Potassium

1994
ACE inhibitors as a shield against diabetic nephropathy.
    Archives of internal medicine, 1996, Feb-12, Volume: 156, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Enalapril; Humans; Kidney Failure, Chronic

1996
The in vitro effects of captopril on the levels of lipid peroxidation and glutathione of erythrocytes in type II diabetes.
    Journal of basic and clinical physiology and pharmacology, 1995, Volume: 6, Issue:3-4

    Topics: Adult; Aged; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Erythrocytes; Glutathione; Humans; Lipid Peroxidation; Middle Aged

1995
Effect of nifedipine, captopril and prazosin on secretory function of pancreatic beta-cells in hypertensive patients with type-2 (non-insulin-dependent) diabetes and in hypertensive non-diabetics.
    Diabetes research and clinical practice, 1996, Volume: 33, Issue:1

    Topics: Adult; Antihypertensive Agents; Blood Glucose; C-Peptide; Calcium Channel Blockers; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Nifedipine; Prazosin

1996
Hypoglycemia associated with the administration of angiotensin-converting enzyme inhibitor in a patient with diabetes mellitus.
    Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Hypoglycemia; Middle Aged

1997
[The hypertensive type II diabetic patient treated with captopril in free general practice (Austrian Safety Study). An indications study].
    Wiener medizinische Wochenschrift (1946), 1997, Volume: 147, Issue:11

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Quality of Life; Treatment Outcome

1997
The diabetic with renal impairment.
    Australian family physician, 1997, Volume: 26, Issue:9

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Coma; Diabetic Nephropathies; Humans; Hypertension; Male

1997
Effect of captopril on renal hemodynamics and renal prostaglandins in early type II diabetic patients with normo-or microalbuminuria.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 1996, Volume: 11, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Humans; Male; Matched-Pair Analysis; Middle Aged; Prostaglandins; Renal Plasma Flow; Thromboxane B2

1996
[The effects of long-term captopril treatment on the evolution of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus].
    Atencion primaria, 1997, Sep-30, Volume: 20, Issue:5

    Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Prevalence; Time Factors

1997
Antihypertensive therapy in type 2 diabetes mellitus.
    The Journal of family practice, 1998, Volume: 47, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Diabetes Mellitus, Type 2; Humans; Hypertension; Middle Aged; Patient Selection; Research Design

1998
Cardiovascular effects of captopril and enalapril in obese Zucker rats.
    European journal of pharmacology, 1999, Jan-22, Volume: 365, Issue:2-3

    Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Cardiomegaly; Diabetes Mellitus, Type 2; Diaphragm; Enalapril; Female; Glucose; In Vitro Techniques; Insulin; Muscle, Skeletal; Nitroprusside; Norepinephrine; Organ Size; Potassium Chloride; Proteinuria; Rats; Rats, Zucker

1999
Severe protracted lichenoid eruption and hyperuricemia following administration of alacepril.
    Internal medicine (Tokyo, Japan), 1999, Volume: 38, Issue:2

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Hypertension; Lichenoid Eruptions; Uremia; Uric Acid

1999
CAPPP trial. Captopril Prevention Project.
    Lancet (London, England), 1999, May-22, Volume: 353, Issue:9166

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diuretics; Humans; Hypertension

1999
[Difficulties in cleaning molar teeth in patient with type 2 diabetes and enalapril medication].
    Duodecim; laaketieteellinen aikakauskirja, 1997, Volume: 113, Issue:2

    Topics: Antihypertensive Agents; Captopril; Dental Calculus; Diabetes Mellitus, Type 2; Enalapril; Humans; Hypertension; Male; Middle Aged; Molar; Risk Assessment; Toothbrushing

1997
The Captopril Prevention Project, further analyses on left ventricular hypertrophy and diabetes.
    Blood pressure, 2001, Volume: 10, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Humans; Hypertension; Hypertrophy, Left Ventricular; Randomized Controlled Trials as Topic

2001
[Prediction, screening and treatment of renal complications of diabetes].
    La Revue du praticien, 2001, Oct-15, Volume: 51, Issue:16

    Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Primary Prevention; Prognosis; Prospective Studies; Proteinuria; Ramipril; Renin-Angiotensin System; Risk Factors; Time Factors

2001
Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients.
    Diabetic medicine : a journal of the British Diabetic Association, 1992, Volume: 9, Issue:8

    Topics: Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Male; Middle Aged; Regression Analysis

1992
Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.
    Journal of human hypertension, 1990, Volume: 4, Issue:6

    Topics: Adult; Aged; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Follow-Up Studies; Humans; Hypertension; Kidney; Male; Middle Aged; Proteinuria; Time Factors

1990
Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy.
    The American journal of medicine, 1990, Volume: 89, Issue:6

    Topics: Captopril; Diabetes Mellitus, Type 2; Enalapril; Glyburide; Humans; Hypertension; Hypoglycemia; Male; Middle Aged

1990
Effect of captopril on glucose concentration. Possible role of augmented postprandial forearm blood flow.
    Diabetes care, 1990, Volume: 13, Issue:11

    Topics: Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Eating; Female; Forearm; Humans; Male; Middle Aged; Regional Blood Flow; Vascular Resistance

1990
Glucose tolerance during chronic captopril therapy in patients with essential hypertension.
    Journal of cardiovascular pharmacology, 1987, Volume: 9, Issue:2

    Topics: Adult; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hypertension; Male; Metabolic Diseases; Middle Aged

1987
Increased insulin-responsiveness by ACE-inhibition in noninsulin dependent diabetes mellitus.
    Advances in experimental medicine and biology, 1989, Volume: 247A

    Topics: Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Forearm; Glucose Clamp Technique; Humans; Insulin; Male; Middle Aged; Peptidyl-Dipeptidase A; Regional Blood Flow

1989
Involvement of prostaglandins in the action of captopril in type II diabetic patients.
    Experimental and clinical endocrinology, 1989, Volume: 93, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Aldosterone; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Dinoprostone; Female; Humans; Male; Middle Aged; Renin; Renin-Angiotensin System; Thromboxane B2

1989
Systemic and renal effects of chronic angiotensin converting enzyme inhibition with captopril in hypertensive diabetic patients.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1989, Volume: 7, Issue:7

    Topics: Albuminuria; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypertension; Kidney; Male; Middle Aged

1989
[Treatment of arterial hypertension in diabetics. Contribution of converting enzyme inhibitors].
    Presse medicale (Paris, France : 1983), 1985, Dec-19, Volume: 14, Issue:44

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Enalapril; Humans; Hypertension; Obesity; Vasodilator Agents

1985
Angiotensin converting enzyme inhibitors in diabetes: experimental and human experience.
    Postgraduate medical journal, 1986, Volume: 62 Suppl 1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Bradykinin; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Humans; Kinins; Male; Metabolic Clearance Rate; Rats; Rats, Inbred Strains

1986
Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.
    The American journal of medicine, 1987, Volume: 82, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Renin-Angiotensin System

1987
Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations.
    The American journal of medicine, 1988, Volume: 85, Issue:3

    Topics: Adult; Aged; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle Aged; Proteinuria

1988
Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides, and captopril.
    The New England journal of medicine, 1988, Dec-15, Volume: 319, Issue:24

    Topics: Biguanides; Captopril; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Sulfonylurea Compounds

1988
[Improved insulin action by ACE inhibition in type-2 diabetics].
    Deutsche medizinische Wochenschrift (1946), 1988, Feb-19, Volume: 113, Issue:7

    Topics: Axilla; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Drug Evaluation; Drug Synergism; Erythrocytes; Glucose; Hemodynamics; Humans; Insulin; Kinins; Muscles; Receptor, Insulin

1988
The effect of captopril on blood pressure and glucose tolerance in hypertensive non-insulin dependent diabetics.
    Postgraduate medical journal, 1986, Volume: 62 Suppl 1

    Topics: Aged; Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hypertension; Male; Middle Aged

1986
[Captopril in hypertensive patients with type II diabetes mellitus].
    Herz, 1987, Volume: 12 Suppl 1

    Topics: Aged; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged

1987
The use of captopril and captopril plus frusemide as antihypertensive agents in non-insulin dependent diabetes.
    Journal of human hypertension, 1987, Volume: 1, Issue:1

    Topics: Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Furosemide; Glucose Tolerance Test; Humans; Hypertension; Insulin; Male; Middle Aged

1987
Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Postgraduate medical journal, 1986, Volume: 62 Suppl 1

    Topics: Blood Glucose; Blood Pressure; Captopril; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged

1986
Captopril in the treatment of hypertension in type I and type II diabetic patients.
    Postgraduate medical journal, 1986, Volume: 62 Suppl 1

    Topics: Adult; Blood Pressure; Captopril; Carbohydrate Metabolism; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electrolytes; Female; Humans; Hypertension; Male; Middle Aged

1986
[Effect of captopril on glucose metabolism in hypertensive subjects with type II diabetes mellitus].
    Bollettino della Societa italiana di biologia sperimentale, 1986, Sep-30, Volume: 62, Issue:9

    Topics: Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged

1986
[Captopril in the control of essential arterial hypertension in diabetic subjects].
    La Clinica terapeutica, 1985, Apr-15, Volume: 113, Issue:1

    Topics: Aged; Captopril; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged; Proline

1985
Captopril in the treatment of hypertension in type I and type II diabetic patients.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1985, Volume: 3, Issue:2

    Topics: Adult; Captopril; Carbohydrate Metabolism; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Hemodynamics; Humans; Hypertension; Kidney Function Tests; Male; Middle Aged; Renal Circulation

1985